Drug firm eyes Asia growth prospects
China Daily | Updated: 2010-01-19 07:55
|
A GlaxoSmithKline Plc technician at the company's plant in Singapore. Glaxo is reinvesting 20 percent of its earnings from poor countries into health infrastructure. Bloomberg News |
SINGAPORE: GlaxoSmithKline Plc forecasts sales growth of as much as 10 percent in the Asia-Pacific region this year, in line with the market and last year's 9 percent increase, spurred by economic expansion in emerging markets.
Photo
